Signals are just the beginning. Fundz delivers what’s next.
Fundz reads more than a dozen live signals on every company, scores each one against your exact market, and weaves in your own network. Each morning you get the few worth your time: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Viatris
Acquired Company
Capra Biosciences, Inc
PittsburghCaliforniaBiotechnologyHealth CareMedical DeviceDescription
On October 8, 2026, Pacira BioSciences, Inc. entered into a Merger Agreement with Viatris Inc. and its wholly owned subsidiary. Under the agreement, Viatris will launch a cash tender offer to acquire all outstanding shares of Pacira at $36.50 per share. The transaction aims to bolster Viatris' portfolio in the healthcare sector. The offer is expected to commence promptly after the agreement was signed.
Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Capra Biosciences, Inc?
Capra Biosciences, Inc was acquired by Viatris, based in Pittsburgh. The deal was reported on October 8, 2026. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).
When did Viatris acquire Capra Biosciences, Inc?
Viatris's acquisition of Capra Biosciences, Inc was reported on October 8, 2026. On October 8, 2026, Pacira BioSciences, Inc. entered into a Merger Agreement with Viatris Inc. and its wholly owned subsidiary. Under the agreement, Viatris will launch a cash tender offer to acquire all outstanding shares of Pacira at $36.50 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Capra Biosciences, Inc do?
Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.